Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
1.585
-0.015 (-0.95%)
Sep 2, 2026, 2:23 PM EDT - Market open

Imunon Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
20
Market Cap
8.89M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022500.00K--
Dec 31, 2021500.00K--
Dec 31, 2020500.00K--
Dec 31, 2019500.00K--
Dec 31, 2018500.00K--
Dec 31, 2017500.00K--
Dec 31, 2016500.00K--
Dec 31, 2015500.00K--
Dec 31, 2014500.00K--
Dec 31, 2013500.00K--
Dec 31, 2012---
Dec 31, 20112.00M--
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 20082.50M--
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Immuron5.34M
Xenetic Biosciences3.26M
Traws Pharma2.73M
Exicure500.00K
AIM ImmunoTech95.00K
Soligenix2.34K
Revenue Rankings